Geode Capital Management, LLC
- SEC CIK
- 0001214717
- Latest filing
- Aug 12, 2026
FNCH holding history
Finch Therapeutics Group, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FNCH overviewAll 13F holders of FNCHFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −6,944−100.0% | Sold outConverted for a 1-for-30 split | Holders |
| Q1 2023 | 208,320 | $81.9K | <0.1% | −1,390−0.7% | Reduced | Holders |
| Q4 2022 | 209,710 | $100.0K | <0.1% | −470−0.2% | Reduced | Holders |
| Q3 2022 | 210,180 | $351.0K | <0.1% | +106,734+103.2% | Added | Holders |
| Q2 2022 | 103,446 | $293.0K | <0.1% | −56,979−35.5% | Reduced | Holders |
| Q1 2022 | 160,425 | $806.0K | <0.1% | +9,263+6.1% | Added | Holders |
| Q4 2021 | 151,162 | $1.51M | <0.1% | −2,387−1.6% | Reduced | Holders |
| Q3 2021 | 153,549 | $2.00M | <0.1% | +13,028+9.3% | Added | Holders |
| Q2 2021 | 140,521 | $1.98M | <0.1% | +140,521 | New | Holders |